Your browser doesn't support javascript.
loading
Impact of hospitalisation on health-related quality of life in patients with chronic heart failure.
Albuquerque de Almeida, Fernando; Al, Maiwenn J; Koymans, Ron; Riistama, Jarno; Pauws, Steffen; Severens, Johan L.
Afiliação
  • Albuquerque de Almeida F; ESHPM - Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, The Netherlands. albuquerquedealmeida@eshpm.eur.nl.
  • Al MJ; ESHPM - Erasmus School of Health Policy and Management, Erasmus University Rotterdam, Rotterdam, The Netherlands.
  • Koymans R; iMTA - Institute for Medical Technology Assessment, Erasmus University Rotterdam, Rotterdam, The Netherlands.
  • Riistama J; Professional Health Services and Solutions, Philips Research Europe, Eindhoven, The Netherlands.
  • Pauws S; Chronic Disease Management, Philips Research Europe, Eindhoven, The Netherlands.
  • Severens JL; Chronic Disease Management, Philips Research Europe, Eindhoven, The Netherlands.
Health Qual Life Outcomes ; 18(1): 262, 2020 Aug 03.
Article em En | MEDLINE | ID: mdl-32746842
BACKGROUND: Empirical identification of the direct impact of hospitalisation in the change in utility could provide an interpretation for some of the unexplained variance in quality of life responses in clinical practice and clinical trials and provide assistance to researchers in assessing the impact of a hospitalisation in the context of economic evaluations. This study had the goal of determining the impact of nonfatal hospitalisations on the quality of life of a cohort of patients previously diagnosed with heart failure by using their quality of life measurements before and after hospitalisation. METHODS: The impact of hospitalisation on health-related quality of life was estimated by calculating the difference in utility measured using the EQ-5D-3L in patients that were hospitalised and had records of utility before and after hospitalisation. The variation in differences between the utilities pre and post hospitalisation was explained through two multiple linear regression models using (1) the individual patient characteristics and (2) the hospitalisation characteristics as explanatory variables. RESULTS: The mean difference between health-related quality of life measurement pre and post hospitalisation was found to be 0.020 [95% CI: - 0.020, 0.059] when measured with the EQ-5D index, while there was a mean decrease of - 0.012 [95% CI: - 0.043, 0.020] in the utility measured with the visual analogue scale. Differences in utility variation according to the primary cause for hospitalisation were found. Regression models showed a statistically significant impact of body mass index and serum creatinine in the index utility differences and of serum creatinine for utilities measured with the visual analogue scale. CONCLUSIONS: Knowing the impact of hospitalisation on health-related quality of life is particularly relevant for informing cost-effectiveness studies designed to assess health technologies aimed at reducing hospital admissions. Through using patient-level data it was possible to estimate the variation in utilities before and after the average hospitalisation and for hospitalisations due to the most common causes for hospital admission. These estimates for (dis) utility could be used in the calculations of effectiveness on economic evaluations, especially when discrete event simulations are the employed modelling technique.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Insuficiência Cardíaca / Hospitalização Idioma: En Ano de publicação: 2020 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Insuficiência Cardíaca / Hospitalização Idioma: En Ano de publicação: 2020 Tipo de documento: Article